[go: up one dir, main page]

TR201815617A2 - A formulation containing dexketoprofen. - Google Patents

A formulation containing dexketoprofen. Download PDF

Info

Publication number
TR201815617A2
TR201815617A2 TR2018/15617A TR201815617A TR201815617A2 TR 201815617 A2 TR201815617 A2 TR 201815617A2 TR 2018/15617 A TR2018/15617 A TR 2018/15617A TR 201815617 A TR201815617 A TR 201815617A TR 201815617 A2 TR201815617 A2 TR 201815617A2
Authority
TR
Turkey
Prior art keywords
formulation containing
containing dexketoprofen
dexketoprofen
pain
pharmaceutically acceptable
Prior art date
Application number
TR2018/15617A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to PCT/TR2018/000136 priority Critical patent/WO2020022976A2/en
Publication of TR201815617A2 publication Critical patent/TR201815617A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu buluş, özellikle kas-iskelet sistemi ağrıları olmak üzere uzun süren ağrı tedavisinde kullanılan, etkin madde olarak deksketoprofen serbest bazı veya farmasötik olarak kabul edilebilir bir tuzunu içeren, sürekli salım yapan tablet formunda olan bir farmasötik bileşim ile ilgilidir.The present invention relates to a pharmaceutical composition in the form of a sustained release tablet containing dexketoprofen free base as an active ingredient or a pharmaceutically acceptable salt thereof, used for the treatment of prolonged pain, particularly musculoskeletal pain.

TR2018/15617A 2017-12-29 2018-10-19 A formulation containing dexketoprofen. TR201815617A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/TR2018/000136 WO2020022976A2 (en) 2017-12-29 2018-12-28 A formulation comprising dexketoprofen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.

Publications (1)

Publication Number Publication Date
TR201815617A2 true TR201815617A2 (en) 2019-07-22

Family

ID=67900930

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.
TR2018/15617A TR201815617A2 (en) 2017-12-29 2018-10-19 A formulation containing dexketoprofen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.

Country Status (2)

Country Link
TR (2) TR201723035A2 (en)
WO (2) WO2019212426A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509A (en) * 2022-10-11 2023-01-17 南京正科医药股份有限公司 Dexketoprofen trometamol injection and preparation process thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4268813A4 (en) * 2020-12-04 2024-07-31 Laboratorios Silanes, S.A. de C.V. Fixed combination medicine for the control and management of neuropathic pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623280A (en) * 2008-07-10 2010-01-13 广东肇庆星湖生物科技股份有限公司 Compound sustained release preparation for easing pain and preparation method thereof
TR201104864A2 (en) * 2011-05-18 2012-12-21 Bi̇lgi̇ç Mahmut Water-soluble formulations containing dexketoprofen.
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets
ES2394888B1 (en) * 2011-06-15 2013-09-23 Farmalider, S.A. PHARMACEUTICAL FORM OF MODIFIED RELEASE OF DEXKETOPROPHENE AND INHIBITOR OF THE PUMP OF PROTONS AND USE OF THE SAME.
WO2013022410A2 (en) * 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509A (en) * 2022-10-11 2023-01-17 南京正科医药股份有限公司 Dexketoprofen trometamol injection and preparation process thereof
CN115607509B (en) * 2022-10-11 2024-01-30 南京正科医药股份有限公司 Dexketoprofen tromethamine injection and preparation process thereof

Also Published As

Publication number Publication date
WO2019212426A2 (en) 2019-11-07
WO2020022976A3 (en) 2020-03-12
TR201723035A2 (en) 2019-07-22
WO2019212426A3 (en) 2019-11-28
WO2020022976A2 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
EA202090860A1 (en) THIADIAZOL ANALOGUES AND METHODS FOR TREATMENT OF CONDITIONS RELATED TO SMN DEFICIENCY
PH12016500420A1 (en) Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
CY1115556T1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES DAVIGATRAN
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
PH12015502632A1 (en) Cxcr7 receptor modulators
EA201691741A1 (en) PHARMACEUTICAL COMPOSITION
MX2016004934A (en) Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy.
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
EA201692298A1 (en) DERIVATIVES OF CARBOXAMIDES
TR201815617A2 (en) A formulation containing dexketoprofen.
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
MX391191B (en) EXTENDED-RELEASE COMPOSITIONS OF ONAPRISTONE AND METHODS.
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
EA201990162A1 (en) PHARMACEUTICAL COMPOSITIONS
EA201891848A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS
EA201500366A1 (en) APPLICATION OF 1-ADAMANTYLETYLOXY-3-MORFOLINO-2-PROPANOL OR ITS PHARMACEUTICALLY ADOPTABLE SALTS IN PHARMACEUTICAL COMPOSITIONS AS A NEURORTHINOPROTECTOR
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
EA201491477A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUPIRTIN